Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...

Triveni Bio Inc., a biotech company advancing novel antibody treatments for I&I disorders, today announced a $115 million ...

WVU Cancer Institute faculty providers were recently recognized by the National Pancreas Foundation for their exceptional ...

though it can lead to relapsing pancreatitis, which can turn chronic. Expect to be in the hospital for up to a week getting pain meds, IV fluids, and other general support. If the root cause is ...

A woman who was diagnosed with pancreatic cancer after experiencing "unbearable pain" while on holiday has now trekked the ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

With weight management being a significant health concern for many, modern medical treatments are offering new solutions to ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate the benefits of using genomics and early ...

Focal liver lesions (FLLs) are abnormal areas of tissue within the liver, often discovered incidentally during imaging tests.

Dr. Sanjay Gupta speaks to researchers exploring the use of naturally occurring viruses that destroy bacteria, to see if they can be used as an alternative treatment method when all else fails, and ...